• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用人类胆碱酯酶活性位点峡谷处的蛋白质波动:开发超强抑制剂设计策略的进一步优化

Exploiting protein fluctuations at the active-site gorge of human cholinesterases: further optimization of the design strategy to develop extremely potent inhibitors.

作者信息

Butini Stefania, Campiani Giuseppe, Borriello Marianna, Gemma Sandra, Panico Alessandro, Persico Marco, Catalanotti Bruno, Ros Sindu, Brindisi Margherita, Agnusdei Marianna, Fiorini Isabella, Nacci Vito, Novellino Ettore, Belinskaya Tatyana, Saxena Ashima, Fattorusso Caterina

机构信息

European Research Centre for Drug Discovery and Development (NatSynDrugs), Università di Siena, Siena, Italy.

出版信息

J Med Chem. 2008 Jun 12;51(11):3154-70. doi: 10.1021/jm701253t. Epub 2008 May 15.

DOI:10.1021/jm701253t
PMID:18479118
Abstract

Protein conformational fluctuations are critical for biological functions, although the relationship between protein motion and function has yet to be fully explored. By a thorough bioinformatics analysis of cholinesterases (ChEs), we identified specific hot spots, responsible for protein fluctuations and functions, and those active-site residues that play a role in modulating the cooperative network among the key substructures. This drew the optimization of our design strategy to discover potent and reversible inhibitors of human acetylcholinesterase and butyrylcholinesterase (hAChE and hBuChE) that selectively interact with specific protein substructures. Accordingly, two tricyclic moieties differently spaced by functionalized linkers were investigated as molecular yardsticks to probe the finest interactions with specific hot spots in the hChE gorge. A number of SAR trends were identified, and the multisite inhibitors 3a and 3d were found to be the most potent inhibitors of hBuChE and hAChE known to date.

摘要

蛋白质构象波动对生物学功能至关重要,尽管蛋白质运动与功能之间的关系尚未得到充分探索。通过对胆碱酯酶(ChEs)进行全面的生物信息学分析,我们确定了负责蛋白质波动和功能的特定热点,以及那些在调节关键亚结构之间的协同网络中起作用的活性位点残基。这促使我们优化设计策略,以发现能与特定蛋白质亚结构选择性相互作用的人类乙酰胆碱酯酶和丁酰胆碱酯酶(hAChE和hBuChE)的强效且可逆的抑制剂。因此,研究了由功能化连接子以不同间距隔开的两个三环部分作为分子尺度,以探测与hChE峡谷中特定热点的最精细相互作用。确定了许多构效关系趋势,并且发现多位点抑制剂3a和3d是迄今为止已知的hBuChE和hAChE的最有效抑制剂。

相似文献

1
Exploiting protein fluctuations at the active-site gorge of human cholinesterases: further optimization of the design strategy to develop extremely potent inhibitors.利用人类胆碱酯酶活性位点峡谷处的蛋白质波动:开发超强抑制剂设计策略的进一步优化
J Med Chem. 2008 Jun 12;51(11):3154-70. doi: 10.1021/jm701253t. Epub 2008 May 15.
2
Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors.乙酰胆碱酯酶和丁酰胆碱酯酶识别位点的特异性靶向。新型、选择性和高效胆碱酯酶抑制剂的合理设计。
J Med Chem. 2003 Jan 2;46(1):1-4. doi: 10.1021/jm0255668.
3
Discovery of huperzine A-tacrine hybrids as potent inhibitors of human cholinesterases targeting their midgorge recognition sites.石杉碱甲-他克林杂合物作为靶向人类胆碱酯酶中峡识别位点的强效抑制剂的发现。
J Med Chem. 2006 Jun 1;49(11):3421-5. doi: 10.1021/jm060257t.
4
Development of molecular probes for the identification of extra interaction sites in the mid-gorge and peripheral sites of butyrylcholinesterase (BuChE). Rational design of novel, selective, and highly potent BuChE inhibitors.开发用于鉴定丁酰胆碱酯酶(BuChE)中峡部和周边位点额外相互作用位点的分子探针。新型、选择性和高效BuChE抑制剂的合理设计。
J Med Chem. 2005 Mar 24;48(6):1919-29. doi: 10.1021/jm049510k.
5
Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.新型基于多奈哌齐的乙酰胆碱酯酶和丁酰胆碱酯酶抑制剂以及乙酰胆碱酯酶诱导的β-淀粉样蛋白聚集。
J Med Chem. 2008 Jun 26;51(12):3588-98. doi: 10.1021/jm8001313. Epub 2008 Jun 3.
6
Tacrine based human cholinesterase inhibitors: synthesis of peptidic-tethered derivatives and their effect on potency and selectivity.基于他克林的人类胆碱酯酶抑制剂:肽链连接衍生物的合成及其对效力和选择性的影响。
Bioorg Med Chem Lett. 2008 Oct 1;18(19):5213-6. doi: 10.1016/j.bmcl.2008.08.076. Epub 2008 Aug 26.
7
Complexes of alkylene-linked tacrine dimers with Torpedo californica acetylcholinesterase: Binding of Bis5-tacrine produces a dramatic rearrangement in the active-site gorge.亚烷基连接的他克林二聚体与加州电鳐乙酰胆碱酯酶的复合物:双5-他克林的结合导致活性位点峡谷发生显著重排。
J Med Chem. 2006 Sep 7;49(18):5491-500. doi: 10.1021/jm060164b.
8
Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer's disease.双结合位点乙酰胆碱酯酶抑制剂的设计、合成及生物学评价:用于阿尔茨海默病的新型疾病修饰药物
J Med Chem. 2005 Nov 17;48(23):7223-33. doi: 10.1021/jm0503289.
9
Novel heterobivalent tacrine derivatives as cholinesterase inhibitors with notable selectivity toward butyrylcholinesterase.新型异二价他克林衍生物作为胆碱酯酶抑制剂,对丁酰胆碱酯酶具有显著的选择性。
J Med Chem. 2006 Dec 14;49(25):7540-4. doi: 10.1021/jm060742o.
10
Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.抑制剂与人类丁酰胆碱酯酶结合所揭示的胆碱酯酶活性位点峡谷尺寸差异。
Biochemistry. 1997 Dec 2;36(48):14642-51. doi: 10.1021/bi971425+.

引用本文的文献

1
Multitargeting nature of muscarinic orthosteric agonists and antagonists.毒蕈碱型正构激动剂和拮抗剂的多靶点特性。
Front Physiol. 2022 Sep 6;13:974160. doi: 10.3389/fphys.2022.974160. eCollection 2022.
2
Development and structure-activity relationships of tanshinones as selective 11β-hydroxysteroid dehydrogenase 1 inhibitors.丹参酮作为选择性11β-羟基类固醇脱氢酶1抑制剂的开发及其构效关系
Nat Prod Bioprospect. 2022 Sep 22;12(1):36. doi: 10.1007/s13659-022-00358-9.
3
Structure-based virtual screening leading to discovery of highly selective butyrylcholinesterase inhibitors with solanaceous alkaloid scaffolds.
基于结构的虚拟筛选导致发现具有茄科生物碱骨架的高度选择性丁酰胆碱酯酶抑制剂。
Chem Biol Interact. 2019 Aug 1;308:372-376. doi: 10.1016/j.cbi.2019.05.051. Epub 2019 May 30.
4
5-Methyl--(8-(5,6,7,8-tetrahydroacridin-9-ylamino)octyl)-5-indolo[2,3-]quinolin-11-amine: a highly potent human cholinesterase inhibitor.5-甲基-(8-(5,6,7,8-四氢吖啶-9-基氨基)辛基)-5-吲哚并[2,3-]喹啉-11-胺:一种高效的人胆碱酯酶抑制剂。
Medchemcomm. 2017 Apr 28;8(6):1307-1317. doi: 10.1039/c7md00143f. eCollection 2017 Jun 1.
5
Ensemble Molecular Dynamics of a Protein-Ligand Complex: Residual Inhibitor Entropy Enhances Drug Potency in Butyrylcholinesterase.蛋白质-配体复合物的系综分子动力学:残留抑制剂熵增强丁酰胆碱酯酶中的药物效力
Bioenergetics. 2017;6(1). doi: 10.4172/2167-7662.1000145. Epub 2017 Jan 8.
6
Optimization of biguanide derivatives as selective antitumor agents blocking adaptive stress responses in the tumor microenvironment.优化双胍衍生物作为阻断肿瘤微环境中适应性应激反应的选择性抗肿瘤药物。
Drug Des Devel Ther. 2014 Jun 6;8:701-17. doi: 10.2147/DDDT.S59679. eCollection 2014.
7
Disease-modifying anti-Alzheimer's drugs: inhibitors of human cholinesterases interfering with β-amyloid aggregation.疾病修饰性抗阿尔茨海默病药物:干扰β-淀粉样蛋白聚集的人胆碱酯酶抑制剂
CNS Neurosci Ther. 2014 Jul;20(7):624-32. doi: 10.1111/cns.12290.
8
Multifunctional cholinesterase and amyloid Beta fibrillization modulators. Synthesis and biological investigation.多功能胆碱酯酶和β-淀粉样蛋白纤维化调节剂。合成与生物学研究。
ACS Med Chem Lett. 2013 Oct 6;4(12):1178-82. doi: 10.1021/ml4002908. eCollection 2013 Dec 12.
9
Pd-catalyzed amination as an alternative to nucleophilic aromatic substitution for the synthesis of N-alkyltacrines and analogues.钯催化胺化反应作为亲核芳香取代反应的替代方法用于合成N-烷基他克林及其类似物。
Tetrahedron Lett. 2011 Feb 23;52(8):916-919. doi: 10.1016/j.tetlet.2010.12.073.
10
The discovery of potential acetylcholinesterase inhibitors: a combination of pharmacophore modeling, virtual screening, and molecular docking studies.潜在乙酰胆碱酯酶抑制剂的发现:基于药效团模型、虚拟筛选和分子对接研究的组合。
J Biomed Sci. 2011 Jan 21;18(1):8. doi: 10.1186/1423-0127-18-8.